Maravai Lifesciences Holdings Inc (MRVI)
SG&A Expense Growth
17.31%
Quarterly · Period ending:
MRVI SG&A Expense Growth
Latest reported17.31%period ending
Latest reported17.31%period ending
MRVI Quarterly SG&A Growth (QoQ) (0.00% → 17.31%)
Latest values, visible window
High-resolution chart · PNG
MRVI sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 17.3092% | |
| 79.95% | |
| -80.5577% | |
| 102.5638% | |
| -2.4997% | |
| -4.071% | |
| 5.5159% | |
| -3.6222% | |
| -0.8047% | |
| 6.2555% | |
| -0.9932% | |
| 9.8567% | |
| -8.518% | |
| 3.9459% | |
| 20.8086% | |
| 9.7431% | |
| -15.4789% | |
| 20.495% | |
| 3.9265% | |
| 8.2122% | |
| 4.3841% | |
| -43.6078% | |
| 102.9303% | |
| 28.2837% | |
| -0.8558% | |
| 2.1668% | |
| 0% |